Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03129555 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

Study acronym: DANNOAC-VTE
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 26 of 26 sites
    v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 10 to 26
    v5
  3. Lead sponsor: Danish Heart Foundation to Herlev and Gentofte Hospitalv4 Show 7 more changesShow less
    • Primary completion date: Mar 31, 2020 to Mar 31, 2027
    • Start date: May 1, 2017 to Apr 1, 2023
    • Trial status: Recruiting to Not Yet Recruiting
    • Study sites: 11 to 10
    • Study completion date: Mar 31, 2020 to Mar 31, 2029
    • Study description expanded, about 6 words
    • Collaborators shortened, about 4 words
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 11
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
No randomized head-to-head comparison between the individual Non-vitamin K Antagonist Oral Anticoagulants (NOAC) exists. The DANNOAC-VTE study is a nationwide cluster randomized cross-over study comparing efficacy and safety of the four NOACs, edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in venous thromboembolism across Danish hospitals.
Trial Details
NCT Number NCT03129555
Lead Sponsor Herlev and Gentofte Hospital
Conditions
(from sponsor)		 Deep Vein Thrombosis, Pulmonary Embolism
Related terms Pulmonary Embolism, Venous Thrombosis
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov